Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at or call 800-767-3771 ext.  9339.

Patterson (PDCO - Analyst Report) completed the previously announced acquisition of the National Veterinary Services Limited (NVS) for $135 million. NVS is the largest veterinary distributor located in the U.K. It was a fully owned subsidiary of Dechra Pharmaceuticals PLC and will now operate as a stand-alone subsidiary of Patterson.
The acquisition is expected to expand the geographic reach of PDCO’s Veterinary business. We believe that NVS’ various offerings, including reference laboratory products, should enrich Patterson’s product portfolio. Upon the completion of one year after the closure of the deal, it is projected to boost PDCO’s earnings by 4–5 cents (including one-time expenses). 
Patterson’s Veterinary Supply unit is seen as a key long-term growth driver. However, the business is posting disappointing results, despite tailwinds in the underlying market. This is due to a change in distribution agreement related to nutritional offerings in 2012. 
We believe that the recent tailwind in the North American veterinary market provides ample opportunity for the company to grow. Patterson is also investing in technologies to boost the profitability of its veterinary business. Apart from the macroeconomic factors, the company needs to improve internal execution to avoid loss of market share in the veterinary business to competitors. 
In early 2013, PDCO’s Veterinary business acquired Calif.-based Universal Vaporizer Support, a supplier of cleaning and calibration services for anesthetic vaporizers used in veterinary drugs.
Recently, on Jul 31, Patterson Dental, the company’s core business, acquired Mercer Mastery, a unit of Mercer Advisors. Patterson Dental acquired the entity to leverage its software products portfolio with Mercer’s flagship product, the OnTrack dental practice performance software system.
PDCO has a Zacks Rank #2 (Buy). The company is slated to report its first-quarter fiscal 2014 results on Thursday, Aug 22. Medical stocks such as MWI Veterinary Supply (MWIV - Analyst Report), The Cooper Companies (COO - Analyst Report) and Align Technology (ALGN - Analyst Report) are worth a look. All these stocks carry a Zacks Rank #2 (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%